Company Profile
The Leukemia & Lymphoma Society
Company Overview
The mission of The Leukemia & Lymphoma Society (LLS) is to help cure leukemia, lymphoma, Hodgkin disease, and myeloma and to improve the quality of life of patients and their families.
The LLS is proud to be one of the most efficiently managed nonprofits in the country with more than 72 cents of every dollar spent directly on mission-related activities.
Company History
The Leukemia & Lymphoma Society was established in 1949 as the de Villiers Foundation, named in memory of Robert Roesler de Villiers, a young man who died of leukemia.
The LLS funds research, patient services, community and professional educational programs, as well as advocacy efforts. As a nonprofit organization, we solely rely on the generosity of individuals, corporations and foundations to advance our mission.
As a result of ongoing research, the relative five-year survival rate has more than tripled in the past 47 years for patients with leukemia.
Notable Products / Brands
Team In Training, Light The Night, Pennies For Patients
Notable Accomplishments / Recognition
Research
The LLS funds patient services, educational programs, advocacy efforts, and over 400 researchers worldwide. To date, the LLS has invested more than $550 million in research.
Gleevec, a recently approved drug has been shown to normalize blood counts in many patients with chronic myelogenous leukemia, was developed, in part, with grants awarded by the Society.
Patient Services
The LLS offers a comprehensive array of services to patients and families, including educational information, peer counseling, professional referrals, local support groups, and financial aid.
Last year alone, the LLS made 5.1 million contacts with patients, caregivers and healthcare professionals.
Public & Professional Education
The Leukemia & Lymphoma Society sponsors a range of conferences, meetings, Webcasts and teleconferences each year for physicians, researchers, healthcare professionals and patients.
In 2007, over 447,000 people worldwide enjoyed these educational opportunities.
Advocacy
A strong voice in Washington D.C. to lobby Congress in support of issues that impact research and patient care. The LLS endorses:
Increased federal funding for biomedical research
Collaborative public-private sector research efforts
Patient protection legislation that guarantees all healthcare consumers certain fundamental rights, including the right to care in a clinical trial.